This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others ... pelvis and around the liver. Vicryl ...

"Reasonable Doubt" has cast Joseph Sikora as a series regular for its upcoming third season, Variety has learned.

Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

Biopharmaceutical company Incyte (Nasdaq: INCY) has reported encouraging results from its Phase 3 STOP-HS clinical trials evaluating povorcitinib, an oral JAK1 inhibitor, for moderate to severe ...

Povorcitinib is an oral Janus kinase 1 selective inhibitor that works to reduce the overactive inflammatory signaling pathway seen in HS.

Governor Glenn Youngkin signed a slew of bills related to his “compete to win” priorities. The bipartisan efforts are meant ...

This program is in place for prescriptions of cyclosporine ophthalmic solution 0.1% (VEVYE, Harrow) and promises a $59 price ...

Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA interference approach can set it apart from its peers. | Despite growing competition ...

The Prince Edward Island Regulatory and Appeals Commission (IRAC) announced a one-cent change to regular gas prices overnight, bringing the pump prices for regular, unleaded gasoline to a range of 163 ...